Ionis Pharmaceuticals, Inc.
OLIGONUCLEOTIDE MEDIATED NO-GO DECAY

Abstract:

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide that induces no-go decay of a target mRNA. In certain embodiments, the modified oligonucleotide is complementary to a region within the 3' half of the coding region of the target mRNA.